SalaryGuide
AboutPricingFor Employers

Marketing jobs

2 marketing jobs

Haemonetics Corp. logo
7 weeks ago

Growth Marketing Manager, Boston Hybrid

Haemonetics Corp.

Boston, MA (Unknown)Full time$104K/yr – $176K/yr
Haemonetics Corp. logo
4 months ago

VP of Global Marketing, Interventional Technologies

Haemonetics Corp.

USA (Unknown)Full time$210K/yr – $357K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

2 jobs
Haemonetics Corp. logo

Growth Marketing Manager, Boston Hybrid

Haemonetics Corp.

Boston, MA (Unknown)

$104K/yr - $176K/yrIn-houseFull-timeMid level8+ years exp.
7 weeks ago
Haemonetics Corp. logo

VP of Global Marketing, Interventional Technologies

Haemonetics Corp.

USA (Unknown)

$210K/yr - $357K/yrIn-houseFull-timeSenior level10+ years exp.
4 months ago
Haemonetics Corp. logo
Haemonetics Corp.

Growth Marketing Manager, Boston Hybrid

Boston, MA (Unknown)

$104K/yr – $176K/yrMid Level8+ years expFull time

Posted 7 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own end-to-end demand generation with multi-channel campaigns, funnel optimization, and cross-functional alignment to deliver pipeline and measurable impact.

  • Campaign Orchestration: Translate business priorities into scalable, multi-channel demand gen programs tied to measurable outcomes.
  • Lead Lifecycle & Tech: Own end-to-end lead management and data integration between marketing systems and CRM for clean reporting.
  • Events & Collaboration: Use events as growth levers while partnering with marketing and sales to steer execution and analytics.

Job Description

Responsibilities

  • As a Growth Marketing Manager, you will be at the centre of our demand generation efforts, driving scalable growth across business units. Acting as the engine of top‑of‑funnel performance, you will shape how we generate pipeline, improve conversion, and measure marketing impact.
  • You will work in close collaboration with marketing and sales teams to translate business priorities into structured, effective campaigns, while building the processes and tools that enable consistent and measurable marketing execution.
  • In this role, you will design and lead integrated demand generation programmes that create awareness, engage target audiences, and deliver qualified pipeline. You will connect strategy with execution by developing multi-channel campaigns and ensuring they are built on clear frameworks and measurable outcomes.
  • You will take ownership of how campaigns are planned, executed, and optimised, introducing scalable processes and improving efficiency through automation.
  • Events and tradeshows will also be part of your scope, used as strategic levers to drive engagement and business growth.
  • A key part of your role will be to manage the end-to-end lead lifecycle, from capture through nurturing and conversion, continuously improving funnel performance using data and insights.
  • You will also oversee marketing technologies and data, ensuring strong integration between platforms such as HubSpot and Salesforce, and enabling clear reporting and performance tracking.

Requirements

  • 8–10 years of experience in demand generation, growth marketing, or marketing operations, ideally in a B2B environment
  • 3-5 years of hands-on experience with marketing automation platforms (such as HubSpot) and CRM systems (e.g. Salesforce)
  • 3-5 years of experience managing website strategy as a growth channel, including SEO/GEO, conversion rate optimization (CRO), user experience, and content-led demand generation
  • Proven ability to design and optimise multi-channel campaigns that drive pipeline and conversion
  • Experience managing the full lead lifecycle, including segmentation, scoring, and nurture programmes
  • Strong analytical mindset, with the ability to translate data into actionable insights
  • Travel Expectations: Regular ~25%; Including weekends as needed
  • Beyond your technical expertise, you are a collaborative and results-driven professional. You are comfortable working cross-functionally, influencing stakeholders, and navigating a global environment with multiple priorities.

Benefits

  • In addition to compensation, the Company offers a competitive suite of benefits to its employees, including without limitation, a 401(k) with up to a 6% employer match and no vesting period, an employee stock purchase plan, “flexible time off” for salaried employees and, for hourly employees, accrual of three to five weeks’ vacation annually (based on tenure), accrual of up to 64 hours (annually) of paid sick time, paid and/or floating holidays, parental leave, short- and long-term disability insurance, tuition reimbursement, and/or health and welfare benefits.
Haemonetics Corp. logo

Haemonetics Corp.

4.2 Glassdoor

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Founded in 1971
Boston, Massachusetts, USA
2.5K employees (38 in marketing)
www.haemonetics.com
88% recommend to a friend
78% CEO approval

Traffic Signals

Monthly Visitors
40.5K
Monthly Google Ads Budget
$29
Traffic Source Mix
Search
43.1%
Direct
43.7%
Referral
8%
Social
3.2%
Paid
1.9%

Headcount Trend

Current headcount: ~2.5K

Marketing Team

Marketing Team Size
38 (2% of company)
Marketing Roles Posted (Last 30 Days)
2

Funding

Total Funding
$1.7B
Last Raise
$600M
Post IPO Debt, 2 years ago

Funding History

  • May 2024
    Post IPO Debt • $600M
  • Mar 2021
    Post IPO Equity • $435M
  • May 2019
    Post IPO Equity • $10M

Recent News

Haemonetics price target raised to $90 from $75 at BofA
Dec 8, 2025 • TipRanks
BofA Securities Maintains Haemonetics(HAE.US) With Hold Rating, Raises Target Price to $90
Dec 8, 2025 • 富途牛牛
Haemonetics (HAE): Reassessing Valuation After a 55% Three-Month Share Price Surge
Dec 8, 2025 • simplywall.st
Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates
Dec 6, 2025 • sharewise.com
Should You Be Adding Haemonetics (NYSE:HAE) To Your Watchlist Today?
Dec 6, 2025 • Yahoo Finance
Capital Fund Management S.A. Makes New $995,000 Investment in Haemonetics Corporation $HAE
Dec 6, 2025 • Defense World
Haemonetics Corporation (NYSE:HAE) Enhances Medical Innovation
Dec 6, 2025 • Kalkine Media
Haemonetics stock hits 52-week high at $85.07 By Investing.com
Dec 5, 2025 • Investing.com Canada
Haemonetics leverages insights from MassWomen conference
Dec 5, 2025 • Traders Union
Boston Partners Buys 11,738 Shares of Haemonetics Corporation $HAE
Nov 29, 2025 • MarketBeat
Q1 EPS Estimates for Haemonetics Boosted by Zacks Research
Nov 28, 2025 • MarketBeat
What risks investors should watch in Haemonetics Corporation stock - Portfolio Risk Summary & Fast Moving Market Watchlists
Nov 27, 2025 • BỘ NỘI VỤ
Q3 EPS Estimates for Haemonetics Decreased by Zacks Research
Nov 27, 2025 • MarketBeat
Is There Opportunity in Haemonetics After Shares Surge 57% on Expansion News?
Nov 27, 2025 • simplywall.st
Haemonetics Reaches Analyst Target Price
Nov 26, 2025 • Nasdaq
Haemonetics stock holds Buy rating at BTIG on plasma segment strength
Nov 21, 2025 • Investing.com UK
BTIG Reiterates Haemonetics (HAE) Buy Recommendation
Nov 21, 2025 • Nasdaq
Haemonetics (HAE) Price Target Increased by 11.07% to 88.03
Nov 17, 2025 • Nasdaq
Interpreting Haemonetics (HAE) International Revenue Trends
Nov 17, 2025 • Yahoo Finance
Haemonetics Hits 80-Plus Relative Strength Rating Benchmark
Nov 14, 2025 • Investor's Business Daily
Raymond James raises Haemonetics stock price target to $90 on strong results
Nov 14, 2025 • Investing.com
Haemonetics (HAE): Assessing Valuation After Profit Beat and Completion of Major Buyback
Nov 13, 2025 • simplywall.st
5 Insightful Analyst Questions From Haemonetics’s Q3 Earnings Call
Nov 12, 2025 • Yahoo Finance
Haemonetics Shows Rising Relative Strength; Still Shy Of Key Threshold
Nov 11, 2025 • Investor's Business Daily
Key metrics from Haemonetics Corporation’s quarterly data - Weekly Trade Report & Low Risk High Reward Trade Ideas
Nov 10, 2025 • newser.com
SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million
Nov 8, 2025 • The Globe and Mail
SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million
Nov 8, 2025 • The Motley Fool
Will Haemonetics’ (HAE) Margin Gains and Upbeat Guidance Recast Its Long-Term Growth Narrative?
Nov 8, 2025 • simplywall.st
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $75 to $90
Nov 8, 2025 • 富途牛牛
Haemonetics Corporation (NYSE:HAE) Q2 2026 Earnings Call Transcript
Nov 8, 2025 • Insider Monkey
Can Haemonetics' (HAE) Rising Profits Offset Revenue Headwinds in Its Competitive Strategy?
Nov 8, 2025 • Yahoo Finance
Needham Maintains Haemonetics (HAE) Buy Recommendation
Nov 8, 2025 • Nasdaq
Why Haemonetics Stock Was on Fire Thursday
Nov 7, 2025 • The Motley Fool
Why Haemonetics Stock Jumped 30%?
Nov 7, 2025 • Trefis
Haemonetics Is Still Undervalued, Even After The Rally (NYSE:HAE)
Nov 7, 2025 • Seeking Alpha
Haemonetics (NYSE:HAE) Shares Gap Up Following Strong Earnings
Nov 7, 2025 • Defense World
A Piece Of The Puzzle Missing From Haemonetics Corporation's (NYSE:HAE) 36% Share Price Climb
Nov 7, 2025 • simplywall.st
Haemonetics Reports Improved Profitability Amid Revenue Decline
Nov 7, 2025 • The Globe and Mail
A Piece Of The Puzzle Missing From Haemonetics Corporation's (NYSE:HAE) 36% Share Price Climb
Nov 7, 2025 • Sahm
Haemonetics Taking Prudent View on Guidance After Plasma Recovery, BofA Says
Nov 7, 2025 • marketscreener.com
Haemonetics Reports Improved Profitability Amid Revenue Decline
Nov 7, 2025 • TipRanks
BTIG Maintains Haemonetics (HAE) Buy Recommendation
Nov 7, 2025 • Nasdaq
Haemonetics: Fiscal Q2 Earnings Snapshot
Nov 6, 2025 • Connecticut Post
Haemonetics Corp (HAE) Q2 2026 Earnings Call Highlights: Strong Plasma Growth and Margin ...
Nov 6, 2025 • Yahoo Finance
Why Are Haemonetics (HAE) Shares Soaring Today
Nov 6, 2025 • Yahoo Finance
Haemonetics (HAE) Reports Q2 Earnings: What Key Metrics Have to Say
Nov 6, 2025 • Yahoo Finance
Haemonetics Corporation (HAE) Q2 FY2026 earnings call transcript
Nov 6, 2025 • Yahoo Finance
Haemonetics Q2 Profit Climbs, Lifts FY26 Adj. EPS View; Stock Up
Nov 6, 2025 • Nasdaq
Haemonetics earnings beat by $0.16, revenue topped estimates
Nov 6, 2025 • Investing.com
Haemonetics shares rise 3% as Q2 results top expectations, guidance raised
Nov 6, 2025 • Investing.com Australia
Haemonetics Corporation Q2 Fiscal 2026 Results
Nov 6, 2025 • TradingView
Haemonetics (NYSE: HAE) posts second-quarter FY2026 results on IR site; webcast 8 a.m. ET
Nov 6, 2025 • Stock Titan
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Nov 6, 2025 • PR Newswire
Haemonetics (NYSE:HAE) Delivers Impressive Q3, Stock Jumps 12.8%
Nov 6, 2025 • Yahoo Finance
Haemonetics (NYSE:HAE) Delivers Impressive Q3, Stock Jumps 12.8%
Nov 6, 2025 • The Globe and Mail
Why Are Haemonetics (HAE) Shares Soaring Today
Nov 6, 2025 • TradingView
Haemonetics Faces Price Target Reduction Amid Financial Announcements
Nov 6, 2025 • timothysykes.com
Haemonetics stock rises as BTIG raises price target on strong earnings
Nov 6, 2025 • Investing.com
Haemonetics Reveals Fiscal Year 2026 Earnings Date Amid New Price Target Shift
Nov 6, 2025 • StocksToTrade
Haemonetics Corp Bottom Line Climbs In Q2
Nov 6, 2025 • Nasdaq
Haemonetics: Fiscal Q2 Earnings Snapshot
Nov 6, 2025 • marketscreener.com
Haemonetics Corp (HAE) Q2 2026 Earnings Call Highlights: Strong
Nov 6, 2025 • GuruFocus
Automated trading signals detected on Haemonetics Corporation - Weekly Investment Recap & Smart Swing Trading Alerts
Nov 6, 2025 • newser.com
Using AI based signals to follow Haemonetics Corporation - Weekly Market Summary & Low Drawdown Investment Ideas
Nov 5, 2025 • newser.com
Haemonetics (HAE): Evaluating Valuation After Earnings Beat and Ongoing Competitive Pressures
Nov 5, 2025 • simplywall.st
Haemonetics Q2 2026 Earnings Preview
Nov 5, 2025 • MSN
What To Expect From Haemonetics’s (HAE) Q3 Earnings
Nov 5, 2025 • Yahoo Finance
Haemonetics Corporation (HAE) is Navigating Challenges Through Earnings Growth
Nov 4, 2025 • Yahoo Finance
Haemonetics Corporation (HAE) is Navigating Challenges Through Earnings Growth
Nov 4, 2025 • Insider Monkey
Haemonetics Q2 FY26 Earnings: A Critical Juncture for the Stock
Nov 4, 2025 • AD HOC NEWS
Should You Hold Haemonetics Corporation (HAE)?
Nov 3, 2025 • Yahoo Finance
How Recent Developments Are Shaping the Haemonetics Investment Story
Oct 28, 2025 • Yahoo Finance
Haemonetics (HAE): Buy, Sell, or Hold Post Q2 Earnings?
Oct 27, 2025 • Yahoo Finance
Haemonetics (HAE): Buy, Sell, or Hold Post Q2 Earnings?
Oct 27, 2025 • The Globe and Mail
Riverwater Partners LLC Sells 5,091 Shares of Haemonetics Corporation $HAE
Oct 27, 2025 • MarketBeat
Can Haemonetics' (HAE) Surprise Revenue Beat Offset Sector Headwinds in the Long Run?
Oct 23, 2025 • simplywall.st
Unpacking Q2 Earnings: Haemonetics (NYSE:HAE) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
Oct 20, 2025 • Yahoo Finance
Medical Devices & Supplies - Specialty Stocks Q2 Results: Benchmarking Haemonetics (NYSE:HAE)
Oct 19, 2025 • Yahoo Finance
How Will Weak Organic Sales Shape Haemonetics’ (HAE) Growth Strategy and Future Outlook?
Oct 16, 2025 • Yahoo Finance
Assessing Haemonetics After Recent Regulatory Approval and a 34% Decline in 2025
Oct 15, 2025 • Yahoo Finance
Can volume confirm reversal in Haemonetics Corporation - 2025 Earnings Surprises & Long-Term Investment Growth Plans
Oct 11, 2025 • newser.com
Risk vs reward if holding onto Haemonetics Corporation - 2025 Big Picture & Long-Term Growth Stock Strategies
Oct 11, 2025 • newser.com
Haemonetics (HAE): Analyst Downgrades Spark New Discussion on Valuation and Future Growth Potential
Oct 10, 2025 • simplywall.st
Dentsply Sirona, Acadia Healthcare, and Haemonetics Stocks Trade Down, What You Need To Know
Oct 10, 2025 • Yahoo Finance
Haemonetics (NYSE:HAE) Receives Hold (C-) Rating from Weiss Ratings
Oct 9, 2025 • MarketBeat
Haemonetics FY2028 EPS Forecast Decreased by Zacks Research
Oct 9, 2025 • Defense World
FY2028 EPS Estimates for Haemonetics Cut by Zacks Research
Oct 8, 2025 • MarketBeat
Haemonetics (NYSE:HAE) Price Target Cut to $64.00 by Analysts at Citigroup
Oct 8, 2025 • Defense World
Q1 EPS Estimates for Haemonetics Cut by Zacks Research
Oct 8, 2025 • Defense World
Citigroup Maintains Haemonetics (HAE) Buy Recommendation
Oct 8, 2025 • Nasdaq
Citigroup Lowers Haemonetics (NYSE:HAE) Price Target to $64.00
Oct 7, 2025 • MarketBeat
Q1 EPS Estimates for Haemonetics Decreased by Zacks Research
Oct 7, 2025 • MarketBeat
Citigroup Lowers Price Target for Haemonetics (HAE) to $64.00 | HAE Stock News
Oct 7, 2025 • GuruFocus
Hunter Perkins Capital Management LLC Acquires Shares of 7,100 Haemonetics Corporation $HAE
Oct 6, 2025 • MarketBeat
What the Recent FDA Plasma Guidance Means for Haemonetics Investors in 2025
Oct 4, 2025 • simplywall.st
Haemonetics (NYSE:HAE) Reaches New 12-Month Low - Here's What Happened
Oct 3, 2025 • MarketBeat
Is Haemonetics (HAE) Undervalued? A Fresh Look at the Company’s Current Valuation
Oct 3, 2025 • simplywall.st
Haemonetics (HAE): Evaluating Valuation After Recent Share Price Weakness and Continued Earnings Growth
Oct 2, 2025 • Yahoo Finance
What Haemonetics (HAE)'s Exposure to Tariff Risks on Medical Device Imports Means for Shareholders
Sep 28, 2025 • simplywall.st
Haemonetics Poised for Recovery and Growth: Buy Rating Affirmed Amid Strategic Actions and Strong Segment Performance
Sep 23, 2025 • TipRanks